Davis Leslie C. 4

What Happened Leslie C. Davis, a director of Edwards Lifesciences Corp (EW), was granted 3,251 restricted stock units (RSUs) on May 8, 2026. The grant is recorded at $0.00 (no cash paid at grant). These RSUs will convert to common shares when they vest; the filing does not show an immediate sale or purchase of shares.

Key Details

• Transaction date and type: 2026-05-08 — Award/Grant (code A) of 3,251 RSUs at $0.00.
• Reported value at grant: $0.00 (no cash consideration reported).
• Shares owned after transaction: Not disclosed in this Form 4 (filing notes it reflects changes in beneficial ownership only).
• Footnote: RSUs granted under the 2020 Nonemployee Directors Stock Incentive Program; they vest 100% at the earlier of one year from the grant date or the issuer’s next annual meeting of stockholders.
• Timeliness: Form filed on 2026-05-08 for a 2026-05-08 transaction (no late filing indicated).

Context This is a routine director compensation award (restricted stock units) rather than an open-market purchase or sale. RSUs typically vest over time and do not represent immediate cash proceeds or selling activity; they simply increase potential future ownership once vested.